Literature DB >> 30904172

Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.

Benjamin C James1, Lava Timsina2, Ryan Graham3, Peter Angelos4, David A Haggstrom5.   

Abstract

BACKGROUND: The incidence of papillary thyroid cancer has increased substantially during the past 15 years, which is likely related to an increased detection of small, nonlethal cancers. Studies have shown that patients may have a similar prognosis when undergoing less aggressive surgical intervention, such as thyroid lobectomy. The objective of this study is to determine whether surgical treatment patterns for papillary thyroid cancer have changed during the past 15 years.
METHODS: We performed a retrospective cohort study evaluating changes in the incidence and proportion of total thyroidectomy versus thyroid lobectomy for histologically confirmed papillary thyroid cancers, using the National Cancer Institute Surveillance, Epidemiology, and End Results cancer registries between 2000 and 2014.
RESULTS: During the study period, 44,537 patients underwent surgical treatment for papillary thyroid cancer, of which 77% were female and 81.3% were white. The incidence of papillary thyroid cancer more than doubled: from 6.2 (5.9-6.5) to 13.0 (12.5-13.4) per 100,000. The proportion of total thyroidectomy among all papillary cases increased from 78.16% in 2000 to 85.67% in 2014, and the proportion of thyroid lobectomy dropped from 16.62% to 11.41%. When stratified by tumor size, we observed a sustained and increasing gap in the proportions of total thyroidectomy and thyroid lobectomy.
CONCLUSION: The incidence of total thyroidectomy has not decreased despite recommendations encouraging consideration of lobectomy for patients with small papillary thyroid cancers. Although these findings could be attributed to the lag between scientific evidence and clinical practice, further work is warranted to explore any additional patient and provider factors that may explain this lack of change.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30904172     DOI: 10.1016/j.surg.2019.01.007

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Thyroid Incidentalomas in Association With Low-Dose Computed Tomography in the National Lung Screening Trial.

Authors:  Holli A Loomans-Kropp; Barbara K Dunn; Barnett S Kramer; Paul Pinsky
Journal:  Am J Epidemiol       Date:  2020-01-31       Impact factor: 4.897

2.  Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.

Authors:  Whitney Sutton; Philip K Crepeau; Joseph K Canner; Shkala Karzai; Dorry L Segev; Aarti Mathur
Journal:  Am J Surg       Date:  2022-02-01       Impact factor: 3.125

3.  KLF4 overexpression decreases the viability, invasion and migration of papillary thyroid cancer cells.

Authors:  Qianzhu Wang; Jian Xu; Yong Chen; Limin Liu
Journal:  Exp Ther Med       Date:  2019-09-02       Impact factor: 2.447

4.  Do carbon nanoparticles really improve thyroid cancer surgery? A retrospective analysis of real-world data.

Authors:  Junsong Liu; Chongwen Xu; Rui Wang; Peng Han; Qian Zhao; Honghui Li; Yanxia Bai; Lifeng Liu; Shaoqiang Zhang; Xiaobao Yao
Journal:  World J Surg Oncol       Date:  2020-05-02       Impact factor: 2.754

5.  Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates - A retrospective study.

Authors:  Malik Azhar; Faisal Aziz; Salama Almuhairi; Mohammad Alfelasi; Ali Elhouni; Rizwan Syed; Humaid O Al-Shamsi; Khaled M Aldahmani
Journal:  Ann Med Surg (Lond)       Date:  2021-03-04

6.  Advancing the Understanding of Vitamin D Status in Post-Thyroidectomy Hypocalcemia.

Authors:  Gurdeep Singh; Fatima Irshaidat; Christopher Lau; Ariel Pedoeem; Christine Feng; Maria Mohammed Fariduddin; Lei Lei Min; Nidhi Bansal
Journal:  Int J Endocrinol       Date:  2021-04-01       Impact factor: 3.257

7.  Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?

Authors:  Tengfei Ma; Haiyang Wang; Jifeng Liu; Jian Zou; Shixi Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-09       Impact factor: 5.555

8.  Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer.

Authors:  Hosu Kim; So Young Park; Jun-Ho Choe; Jee Soo Kim; Soo Yeon Hahn; Sun Wook Kim; Jae Hoon Chung; Jaehoon Jung; Tae Hyuk Kim
Journal:  Cancers (Basel)       Date:  2020-03-08       Impact factor: 6.639

Review 9.  Is Maintaining Thyroid-Stimulating Hormone Effective in Patients Undergoing Thyroid Lobectomy for Low-Risk Differentiated Thyroid Cancer? A Systematic Review and Meta-Analysis.

Authors:  Ho-Ryun Won; Eonju Jeon; Jae Won Chang; Yea Eun Kang; Kunho Song; Sun Wook Kim; Dong Mee Lim; Tae Kwun Ha; Ki-Wook Chung; Hyo-Jeong Kim; Young Joo Park; Bon Seok Koo
Journal:  Cancers (Basel)       Date:  2022-03-13       Impact factor: 6.639

10.  Elective Central Compartment Lymph Node Dissection Does not Increase the Risk of Postoperative Hypoparathyroidism in Patients Treated for Differentiated Thyroid Cancer.

Authors:  Boris Stubljar; Marija Pastorčić Grgić; Ljiljana Mayer; Pavao Perše; Tomislav Tomičević
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.